Moyamoya angiopathy unmasking systemic lupus erythematosus.
Albuminuria
Angiography, Digital Subtraction
Antibodies, Antinuclear
/ immunology
Anticonvulsants
/ therapeutic use
Antirheumatic Agents
/ therapeutic use
Cerebral Angiography
Cerebral Hemorrhage
/ diagnostic imaging
Epilepsy
/ complications
Female
Glucocorticoids
/ therapeutic use
Humans
Hydroxychloroquine
/ therapeutic use
Lupus Erythematosus, Systemic
/ complications
Magnetic Resonance Angiography
Middle Aged
Moyamoya Disease
/ complications
Tomography, X-Ray Computed
epilepsy and seizures
headache (including migraines)
neuroimaging
stroke
systemic lupus erythematosus
Journal
BMJ case reports
ISSN: 1757-790X
Titre abrégé: BMJ Case Rep
Pays: England
ID NLM: 101526291
Informations de publication
Date de publication:
27 Jan 2021
27 Jan 2021
Historique:
entrez:
28
1
2021
pubmed:
29
1
2021
medline:
24
2
2021
Statut:
epublish
Résumé
A 47-year-old woman with history of seizure disorder (semiology of seizure unknown), not well controlled with antiepileptic drugs since last 30 years presented with 1-year history of intermittent throbbing headache. On the day prior to admission, she experienced worst headache, followed by loss of consciousness. On regaining consciousness, she had neck pain without any focal neurological deficit, but examination was marked by positive meningeal signs. She had history of oral ulceration, photosensitivity and small joints pain for which no medical consultancy was sought until. Following relevant investigations, this case came out to be moyamoya angiopathy secondary to underlying systemic lupus erythematosus. She was put on immunosuppressive and immunomodulator as per recommendations. Among neurological symptoms, headache improved dramatically without any further seizure recurrence till the 6 months of follow-up.
Identifiants
pubmed: 33504534
pii: 14/1/e239307
doi: 10.1136/bcr-2020-239307
pmc: PMC7843324
pii:
doi:
Substances chimiques
Antibodies, Antinuclear
0
Anticonvulsants
0
Antirheumatic Agents
0
Glucocorticoids
0
Hydroxychloroquine
4QWG6N8QKH
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Lupus. 2013 May;22(6):629-33
pubmed: 23574743
Lancet Neurol. 2008 Nov;7(11):1056-66
pubmed: 18940695
Mediterr J Rheumatol. 2019 Mar 28;30(1):7-15
pubmed: 32185337
Lupus. 2008 Jul;17(7):679-82
pubmed: 18625642
Korean J Pediatr. 2013 Dec;56(12):545-9
pubmed: 24416051
Clin Rheumatol. 2020 Dec;39(12):3861-3867
pubmed: 32562069
Int J Stroke. 2017 Apr;12(3):246-253
pubmed: 28381201
J Neurosurg. 2009 Nov;111(5):927-35
pubmed: 19463046
Neurol Med Chir (Tokyo). 2019 Oct 15;59(10):361-370
pubmed: 31281171
J Clin Rheumatol. 1998 Dec;4(6):328-32
pubmed: 19078332
Med Princ Pract. 2014;23(3):279-81
pubmed: 23988863
Case Rep Med. 2012;2012:120867
pubmed: 22966233
Pediatr Neurol. 2002 Jan;26(1):68-70
pubmed: 11814740
Rheumatology (Oxford). 2017 Nov 1;56(11):1945-1961
pubmed: 28968809
J Stroke Cerebrovasc Dis. 2020 Aug;29(8):104957
pubmed: 32689603
Korean J Intern Med. 2003 Dec;18(4):244-7
pubmed: 14717235
J Neurol. 2019 Nov;266(11):2838-2847
pubmed: 31422456
N Engl J Med. 2009 Mar 19;360(12):1226-37
pubmed: 19297575
Scand J Rheumatol. 1997;26(5):392-4
pubmed: 9385355
J Clin Neurol. 2019 Jul;15(3):407-409
pubmed: 31286717
Lupus. 2000;9(8):632-6
pubmed: 11035439
Ann Rheum Dis. 2019 Jun;78(6):736-745
pubmed: 30926722
Eur J Neurol. 2015 Jun;22(6):1012-7
pubmed: 25847099
Lupus. 2013 May;22(6):639-43
pubmed: 23651859
Rheumatology (Oxford). 2011 Oct;50(10):1931
pubmed: 21752869
Arthritis Rheumatol. 2019 Sep;71(9):1400-1412
pubmed: 31385462